Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain
Andrew D Cook, Jarrad Pobjoy, Shannon Sarros, Stefan Steidl, Manuela Duerr, Derek C Lacey, John A Hamilton
Annals of the Rheumatic Diseases | BMJ PUBLISHING GROUP | Published : 2013
This work was supported by grants from Morphosys AG and the National Health and Medical Research Council (NHMRC), and by a NHMRC Senior Principal Research Fellowship (JAH).SSt is a full-time employee of MorphoSys AG, Germany. JAH has received consulting fees from MorphoSys AG, Germany (less than US0 000 a year). The University of Melbourne has licensed to MorphoSys AG, Germany, patented technology relating to therapeutically targeting granulocyte-macrophage colony-stimulating factor, for which licensing fees and milestone payments have been made. The other authors state no conflict of interests.